Geron | GERN - Interest Expense On Debt


Geron reported $8.64M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Amgen USD 653M 32M Dec/2025
Bio Techne USD 2.18M 173K Jun/2025
Cassava Sciences USD 129.73M 5.65M Sep/2025
Cytokinetics USD 26.32M 2.06M Sep/2025
Esperion Therapeutics USD 15.08M 1.36M Sep/2024
Exelixis USD 23.4M 3.9M Sep/2023
Genmab DKK 37M 28M Sep/2025
Geron USD 8.64M 128K Sep/2025
Gilead Sciences USD 255M 1000K Dec/2025
Incyte USD 582K 10K Dec/2025
MacroGenics USD 3.34M 2.54M Sep/2025
Novartis USD 281M 8M Sep/2025
Novavax USD 4.24M 96K Sep/2024